Australian Marine Biodiversity As A Source Of New Drugs To Control Neurodegenerative Disease

随着澳大利亚人口的老龄化，阿尔茨海默病和帕金森病等神经退行性疾病的影响正在迅速上升。迫切需要开发新的和更好的药物来治疗这些使人衰弱的疾病的症状和根本原因。从历史上看，世界上大多数的药物都是从生物多样性（即植物、微生物和动物）中提取的。作为少数几个生物多样性巨大的国家之一，澳大利亚处于加速和集中从自然中寻找药物的理想位置。该项目将探索澳大利亚生物多样性的一个特别有前途的池，它的海洋生态系统，作为开发治疗神经退行性疾病的新药的灵感来源。

With the aging of Australia's population the impact of neurodegenerative diseases such as Alzheimer's and Parkinson's is rapidly on the rise. There is an urgent need to develop new and better drugs to treat the symptoms and underlying cause of these debilitating diseases. Historically, the majority of the world's pharmaceuticals have been drawn from biodiversity (ie plants, microbes and animals). As one of the few megabiodiverse nations, Australia is ideally positioned to accelerate and focus the search for drugs from nature. This project will explore an exceptionally promising pool of Australian biodiversity, its marine ecosystems, as a source of inspiration for the development of new drugs to treat neurodegenerative diseases.